| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 12/31/2003 | WO2003055916A3 Adiponectin fragments and conjugates |
| 12/31/2003 | WO2003055912A3 Secreted proteins |
| 12/31/2003 | WO2003046129A3 Compositions for the derivation of germ cells from stem cells and methods of use thereof |
| 12/31/2003 | WO2003045997A3 Fusion proteins containing tlp peptides |
| 12/31/2003 | WO2003044166A3 METHODS AND COMPOSITIONS FOR REGULATION OF GENE EXPRESSION THROUGH MODULATION OF mRNA TURNOVER |
| 12/31/2003 | WO2003040335A3 Engineering of leader peptides for the secretion of recombinant proteins in bacteria |
| 12/31/2003 | WO2003040301A3 Cell cycle progression proteins |
| 12/31/2003 | WO2003035722A8 Methods for controlling peptide solubility, chemically modified peptides, and stable solvent systems for producing same |
| 12/31/2003 | WO2003033734A3 Diagnostic tests for the diagnosis of copper storage disease |
| 12/31/2003 | WO2003033667A3 Use of mx gtpases in the prognosis and treatment of cancer |
| 12/31/2003 | WO2003025174A3 Regulation of human mrp1-like protein |
| 12/31/2003 | WO2003024316A3 Pore-forming agents for orthopedic cements |
| 12/31/2003 | WO2003022996A3 Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same |
| 12/31/2003 | WO2003022879B1 Peptides mimicking a cryptic epitope of gp41 hiv-1 and antibodies directed against them |
| 12/31/2003 | WO2003020759A9 A caspase- 8 binding protein, its preparation and use |
| 12/31/2003 | WO2003010286A9 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 12/31/2003 | WO2003010176A3 Protein-nucleic acid complexes |
| 12/31/2003 | WO2003006492A3 Biologically active peptides |
| 12/31/2003 | WO2002101232A3 Bace interacting proteins |
| 12/31/2003 | WO2002097059B1 Chromosome-based platforms |
| 12/31/2003 | WO2002088347A3 Aav helper plasmids for helper virus-free packaging and pseudo typification of aav vectors |
| 12/31/2003 | WO2002079427A3 84226, a novel human cation transporter family member and uses thereof |
| 12/31/2003 | WO2002077648A3 Pathogenic and commensal vaccine antigens |
| 12/31/2003 | WO2002070562A3 Nuclear hormone receptor ligand binding domain |
| 12/31/2003 | WO2002070004A3 Papillomavirus vaccines |
| 12/31/2003 | WO2002067971A3 Use of endostatin in the treatment of ocular neovascularization |
| 12/31/2003 | WO2002062946A9 Identification of novel ms4a gene family members expressed by hematopoietic cells |
| 12/31/2003 | WO2002057469A3 Modulating developmental transitions in plants |
| 12/31/2003 | WO2002053701A9 Epididymal lipocalin gene and uses thereof |
| 12/31/2003 | WO2002050111A9 Isolated laminin 10 |
| 12/31/2003 | WO2002042444A3 Fungal gene cluster associated with pathogenesis |
| 12/31/2003 | WO2002040718A3 Method to identify genes associated with chronic myelogenous leukemia |
| 12/31/2003 | WO2002040671A3 Immunoglobulin superfamily proteins |
| 12/31/2003 | WO2002038766A3 Human tumor necrosis factor receptor |
| 12/31/2003 | WO2002031198A3 Cancer-linked genes as targets for chemotherapy |
| 12/31/2003 | WO2001064710A8 Sulfated ccr5 peptides for hiv-1 infection |
| 12/31/2003 | WO2000043409A3 Alpha-conotoxin peptides |
| 12/31/2003 | CN1464907A Novel rice gene regulating salt stress tolerance |
| 12/31/2003 | CN1464790A T cell receptor fusions and conjugates and methods of use thereof |
| 12/31/2003 | CN1464068A Human brain tissue specificity molecular marker LRRC4 |
| 12/31/2003 | CN1464062A Expression vector pBVTB, its construction method and use in HCV vaccin research |
| 12/31/2003 | CN1464061A Bean culture pattern schema regulating gene and use thereof |
| 12/31/2003 | CN1464060A Bridsfoot trefoil pattern schema and anthotaxis structure regulating gene encoding protein and use thereof |
| 12/31/2003 | CN1464059A Actinine fluorescent protein novel gene and its cloning, expression and use |
| 12/31/2003 | CN1464058A Tumor-repressed fusion protein, its encoding gene and use thereof |
| 12/31/2003 | CN1464057A Chemokine-like factor superfamily having skeletal muscle stimulating activity and immunoregulation function |
| 12/31/2003 | CN1463984A Medicinal collagen material and its making process |
| 12/31/2003 | CN1463983A Process for preparing albumin proserum using trans-gene animal |
| 12/31/2003 | CN1463982A Human interleukin-17 receptor-like protein, its coding gene and use thereof |
| 12/31/2003 | CN1463978A Carcinoma related gene and protein coded thereby |
| 12/31/2003 | CN1463781A Process for extracting inner cell product using cytoclasis and double aqueous phase extraction technology |
| 12/31/2003 | CN1132937C Nucleic acid markers for rice blast resistance genes and rice blast resistance genes isolated by the use of these markers |
| 12/31/2003 | CN1132845C Improved method for obtaining isulin precursor having correctly-bonded cystine bond |
| 12/31/2003 | CN1132844C Preparation method for engineering bateria for recombination of human leucocyte medium-18 and its product thereof |
| 12/31/2003 | CN1132843C Simple ferredoxin separating process |
| 12/31/2003 | CN1132842C Present invention relates to extraction of recombinant proteins produced by prokaryotic microorganism, especially by E. Coli |
| 12/31/2003 | CN1132586C Immunomodulating compositions from bile |
| 12/31/2003 | CA2829581A1 Recombinant measles viruses expressing epitopes of antigens of rna viruses - use for the preparation of vaccine compositions |
| 12/31/2003 | CA2740137A1 Nucleic acid sequences and methods of use for the production of plants with modified polyunsaturated fatty acids |
| 12/31/2003 | CA2493834A1 Recombinant measles viruses expressing epitopes of antigens of rna viruses - use for the preparation of vaccine compositions |
| 12/31/2003 | CA2491803A1 Novel kcnq polypeptides, modulators thereof, and their uses in the treatment of mental disorders |
| 12/31/2003 | CA2491196A1 Materials and methods for inductions of immune tolerance |
| 12/31/2003 | CA2491070A1 Immunogenic polypeptide isolated from mycobacterium avium subspecies paratuberculosis and uses thereof |
| 12/31/2003 | CA2491038A1 Dna sequence and recombinant production of the grass pollen allergen phl p4 |
| 12/31/2003 | CA2490746A1 Nucleotide sequences that code for torsin genes, torsin proteins, and methods of using the same to treat protein-aggregation |
| 12/31/2003 | CA2490517A1 Polynucleotides and polypeptides coded by said polynucleotides involved in the synthesis of diketopiperazine derivatives |
| 12/31/2003 | CA2490449A1 Adjuvant-free peptide vaccine |
| 12/31/2003 | CA2490399A1 Novel raag10 cell surface target and a family of antibodies recognizing that target |
| 12/31/2003 | CA2490360A1 Pegylated factor vii glycoforms |
| 12/31/2003 | CA2490195A1 A non-blended soybean oil with high oleic acid content |
| 12/31/2003 | CA2490139A1 Novel bartonella antigen lysate extracts for use in elisa diagnostic |
| 12/31/2003 | CA2490063A1 Methods of modulating cytokinin related processes in a plant using b3 domain proteins |
| 12/31/2003 | CA2490004A1 Plastid division and related genes and proteins, and methods of use |
| 12/31/2003 | CA2489930A1 Methods and means to promote gut absorption |
| 12/31/2003 | CA2489907A1 Mhc class ii haplotype specific immunodominancy of peptides derived from rsv fusion (f) and attachement (g) proteins |
| 12/31/2003 | CA2489803A1 Compositions and methods for modulating lymphocyte activity |
| 12/31/2003 | CA2489348A1 Apo-2 ligand/trail variants and uses thereof |
| 12/31/2003 | CA2489057A1 Compositions and methods for apo-b48 and apo-b100 assay |
| 12/31/2003 | CA2489052A1 Infectious cdna of an approved vaccine strain of measles virus, use for immunogenic compositions |
| 12/31/2003 | CA2489024A1 Use of pp2a phosphatase modulators in the treatment of mental disorders |
| 12/31/2003 | CA2488856A1 Packaged virus-like particles for use as adjuvants: method of preparation and use |
| 12/31/2003 | CA2488848A1 Protein extraction from canola oil seed meal |
| 12/31/2003 | CA2486490A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 12/30/2003 | US6670528 Transformed with DNA that encodes a protein linked to a promoter which can improve its resistance to dehydration, low temperature and salt; free from dwarfing |
| 12/30/2003 | US6670526 Arabidopsis ESD4 gene and method to control flowering time |
| 12/30/2003 | US6670467 Nucleotide sequences for tissue-independent or constitutive promoters for genes encoding actin-2, enolase, Gos-2 and L41 |
| 12/30/2003 | US6670466 Human endogenous retrovirus in breast cancer |
| 12/30/2003 | US6670465 Mutations of the gene may cause a type of X-linked congenital stationary night blindness known as incomplete CSNB, and may also cause Aaland Island Eye Disease |
| 12/30/2003 | US6670464 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 12/30/2003 | US6670463 Polynucleotides that encode carcinoma proteins or antibodies or immune system cells specific for such proteins. |
| 12/30/2003 | US6670462 Nucleotide sequences coding polypeptide for use in the treatment of hepatitis and liver disorders |
| 12/30/2003 | US6670460 Method of detection of alterations in MSH5 |
| 12/30/2003 | US6670452 Non-naturally occurring lipoprotein particle |
| 12/30/2003 | US6670451 Netrins |
| 12/30/2003 | US6670450 Polypeptide that inhibits the differentiation of myoblasts into myotubes as well as the transactivation function of p53, a transcription factor involved in tumor suppression. |
| 12/30/2003 | US6670449 Hybrid molecules and their use for optically detecting changes in cellular microenvironments |
| 12/30/2003 | US6670448 Peptide for use in the treatment of gastrointestinal inflammation and defects of the blood brain barrier |
| 12/30/2003 | US6670333 Providing exogenous antiangiogenic protein to endothelial cells associated with said tissue |
| 12/30/2003 | US6670329 Isolated hybrid polypeptide |
| 12/30/2003 | US6670328 Inflammatory diseases, xenograft or allograft rejection, asthma |